FDA Part 11 Public Meeting Part 11 Simplification, and a Return to the Original Intent Presented By: Martin Browning, EduQuest, Inc.

Slides:



Advertisements
Similar presentations
AFACT eCOO WG interim meeting - Conference Call 1st March of 2011 Mahmood Zargar eCOO Experiences and Standards.
Advertisements

What is GARP®? GARP® is an Acronym for Generally Accepted Recordkeeping Principles ARMA understands that records must be.
11 June 2004© 2004 Wimmer Systems, Inc. 1 Cryptography Facilitates Record Security and Integrity Presented By Derek Wimmer President Wimmer Systems, Inc.
15 The Health Record.
21 CFR Part 11 Regulatory Overview and What’s New with the FDA
Standard Operating Procedure What is an SOP? Who should Write? Format and Content of SOPs How to Implement Managing Change Control Who is Responsible?
New GAMP Good Practice Guide for Electronic Record and Signature Compliance Arthur D. Perez, Ph.D. Chairman, GAMP Americas.
Phone: (919) Fax: (919) CFR Part 11 FDA Public Meeting Comments Presented by: M. Rita.
Case Studies Pat McGee. Why Research? ● To distinguish between rival plausible hypotheses. [Campbell 1994] ● To attack proposed scientific theories. [Popper.
Coping with Electronic Records Setting Standards for Private Sector E-records Retention.
Laboratory Notebook FITT (Fostering Interregional Exchange in ICT Technology Transfer)
Audit Program: Introduction. Our role Located within the Tasmanian Archives and Heritage Office (TAHO), the Government Recordkeeping team.
21 CFR PART 11 REGULATIONS RECOMMENDATIONS FOR CHANGES FDA PUBLIC MEETING ON PART 11 REGULATIONS – JUNE 11, 2004 NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION.
Industry Coalition on 21 CFR Part 11 Recommendations for Achieving Compliance with the Electronic Records and Electronic Signatures Regulation.
Rules for complying with the rules
CDRH Software Regulation
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
Title 21 Code of Federal Regulations 21CFR Part 11
Digitisation: Do it Well, Do it Once Government Recordkeeping Forum Auckland 29 October 2010 Anna Gulbransen, Advisor, Government Recordkeeping Programme.
11/2/991 CDER’s 21 CFR Part 11 Implementation Study Greg Brolund Associate Director, Office of Information Technology, CDER/FDA.
Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum 21 CFR Part 11 Considerations November 14, 2002.
Chapter 7 Database Auditing Models
21 CFR Part 11 A Food Industry Perspective FDA Public Meeting June 11, 2004 Sia Economides Center Director Center for Development of Research Policy and.
Project co-financed by European Union Project co- financed by Asean European Committee for Standardization Implementing Agency1 GMP Workshop Kuala Lumpur.
MethodGXP The Solution for the Confusion.
Wednesday, October 13, 2010 Licensing procedures of a Connecticut Domiciled Insurance Company.
Regulatory Affairs Domain
Comments Presentation for Part11 FDA Public Meeting Docket # 2004N-0133 Venue and Date: 429 L'Enfant Plaza, SW Washington, DC June 11, 2004.
Planning an Audit The Audit Process consists of the following phases:
Enabling learning and assessment Unit 3 – Week 1.
FDA Docket No. 2004N-0133 Themes for Renewal of 21 CFR Part 11 Rule & Guidance by Dr. Teri Stokes, GXP International
Digital Imaging Services Digital Imaging Services – We take information from any format (i.e. Paper, Microfilm, Microfiche, Digital, etc.) and move it.
PwC 21 CFR Part 11 – A Risk Management Perspective Patrick D. Roche 07 March 2003, Washington D.C.
Database Security and Auditing: Protecting Data Integrity and Accessibility Chapter 7 Database Auditing Models.
Massella Ducci Teri Italian approach to long-term digital preservation Policies for Digital Preservation ERPANET Training Seminar.
FDA Public Meeting on Electronic Records and Signatures June 11, 2004 Presentation of the Industry Coalition on 21CFR Part 11 Alan Goldhammer, PhD Chair.
2. Document Management Involves the receipt, tracking and storing of documents, images and multimedia files. Involves the receipt, tracking and storing.
Discover a new level of Data Safety for Automation Technology in line with ISO 900x and FDA 21 CFR 11 Discover a new level of Data Safety for Automation.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Part 11, Electronic Records; Electronic Signatures
Values That Stand The Test of Time A CASE STUDY: The modification of a legacy process control system [The case for data integrity without “Part 11" compliance]
The FDA Regulatory and Compliance Symposium Preparing for the FDA’s Risk-Based Inspections Presented By: Martin Browning, EduQuest, Inc.
PhRMA Perspective on FDA Final Report FDA Advisory Committee on Pharmaceutical Sciences October 20, 2004 G.P. Migliaccio, Pfizer Inc.
Washington State Archives “Going Paperless” Presented by: Leslie Koziara, ERMP May 7, 2009 A GUIDE TO WASHINGTON STATE’S APPROVAL PROCESS FOR THE DESTRUCTION.
DIGITAL SIGNATURE.
Confidential CFR Part 11 Public Meeting The Role of the Technology Provider in the Pharmaceutical Industry Jean Paty, Ph.D. Co-founder.
Part 11 Public Meeting PEERS Questions & Responses The opinions expressed here belong to PEERS members and not the corporate entities with which they are.
Data Integrity # Best Practices & Lessons Learned. Does It Fit Your Organization?
FDA Part 11 Public Meeting Washington, DC June 11, 2004 Paul D’Eramo Executive Director Worldwide Policy & Compliance Management Quality & Compliance Services.
© 2004, Genentech Electronic Records; Electronic Signatures Public Meeting Docket No. 2004N-0133 Kenneth Kornfield, Associate Director, Global Quality.
FDA Public Meeting Electronic Records; Electronic Signatures Docket No. 2004N-0133 Madeleine Kennedy & Michael Rutherford Eli Lilly and Company 11 June.
The world leader in serving science OMNIC DS & Thermo Security Administration 21 CFR Part 11 Tools for FT-IR and Raman Spectroscopy.
DATA MANAGEMENT AND IT IN BA/BE STUDIES DR. SHIVPRAKASH MANAGING DIRECTOR SYNCHRON RESEARCH SERVICES PVT. LTD., INDIA.
1 CHAPTER 5 - b INTERNAL CONTROL OVER FINANCIAL REPORTING.
SEMINAR ON, PRESENTED BY, POONAM Y AGHARA M – PHARM DEPT. OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY L. M. COLLEGE OF PHARMACY AHMEDABAD.
The University, Digitisation and You LRC meeting 5 th June, 2013 Adelaide Parr Records Analyst Records Services.
& UETAESIGN COMPLIANCE. CHANGING LANDSCAPE As contract management transitions into a paperless world, documents must remain compliant with government.
Data Management: Source Documents, Case Report Forms and Electronic Data Thomas Salerno, RN BSN MA Senior Team Lead Cardiology Research Jefferson Clinical.
21 CFR PART 11.
FDA 21 CFR Part 11 Compliance
6. Records Management & Quality Assurance of Data
Retention Breakout Session
The Role of the Technology Provider in the Pharmaceutical Industry
UW-Madison Guidelines for Managing the Records of Departing Employees*
Clinical Trials Validation, 21 CFR Part 11 Compliance
Standard Operating Procedure (SOP) Management Software
GAGEtrak - Calibration Management Software
FDA 21 CFR Part 11 Overview June 10, 2006.
About EverydayComply A Solution designed to:
Change Highlights January 2013
Presentation transcript:

FDA Part 11 Public Meeting Part 11 Simplification, and a Return to the Original Intent Presented By: Martin Browning, EduQuest, Inc.

© 2004 EduQuest, Inc. Part 11 Simplification and a Return to the Original Intent Issues –The reality of the current problem –The simplicity of the original intent –The problem areas –The path forward – simplification

© 2004 EduQuest, Inc. The Reality of the Current Problem Management taken by surprise Realization that Part 11 is not a “Quality” problem A lack of understanding of “validation” A lack of understanding of the “predicate” regulations The quantity of work

© 2004 EduQuest, Inc. The Reality of the Current Problem “Upper management feels…” “We have no consistent …” “Validation is impossible …” “We want to comply …” “We can’t write software according to this …”

© 2004 EduQuest, Inc. The Simplicity of the Original Intent To encourage and facilitate the adoption of technological improvements without a loss in data integrity To provide for no less integrity for electronic data and electronic signatures than for paper based data and signatures To accomplish the above within the existing regulatory framework

© 2004 EduQuest, Inc. The Simplicity of the Original Intent How –Rely on existing FDA recordkeeping regulations –Borrow from industries already involved with electronic data integrity Financial Legal –Apply “common sense” (sometimes referred to as a “risk-based” approach)

© 2004 EduQuest, Inc. The Problem Areas Validation – poorly understood, poorly defined to the software industry Documents vs. records – no distinction made Audit trails – not clearly defined as data change documentation (as in the financial industry) Grandfathering of legacy systems – not allowed

© 2004 EduQuest, Inc. The Problem Areas Archiving – new requirements “interpreted” into the regulation Time stamps – a classic “red herring” issue Electronic copies – more new requirements “interpreted” into the regulation A glossary – all of the above

© 2004 EduQuest, Inc. The Path Forward – Simplification Define computerized system validation as the documented use of good software development practice applied according to intended use (i.e., the risk) of the system Distinguish between documents and records and the way they are created and maintained

© 2004 EduQuest, Inc. The Path Forward – Simplification Point out that audit trails (data change records) are required by predicate regulations Grandfather systems in use prior to 8/20/97 –As long as the predicate regulations are met and until they are retired/replaced

© 2004 EduQuest, Inc. The Path Forward – Simplification Archiving – clarify that the purpose and utility of archived electronic records are the same as for archived paper records –Documenting what happened, and not replaying, redoing, or reprocessing the event Apply common sense to issues such as time stamps, password use, etc.

© 2004 EduQuest, Inc. The Path Forward – Simplification Electronic copies – –Stick with the concept that a copy is an exact copy, not a reinterpretation of data, not data modified into a “universal” format, not a different representation of the data –FDA will find the ability to use/interpret/analyze an exact copy of an electronic record just as it did for many years prior to Part 11 and it will have the benefit of being recognized as “evidence” without confusion or making industry validate conversion processes

© 2004 EduQuest, Inc. The Path Forward – Simplification There is no need to change the text of Part 11 –All of these issues can be dealt with by republishing the text of the regulation while simplifying the interpretation by making the interpretation match what was originally intended